Global Oral Thin Films Market to Reach $8.5 Billion by 2030
The global market for Oral Thin Films estimated at US$3.4 Billion in the year 2022, is projected to reach a revised size of US$8.5 Billion by 2030, growing at a CAGR of 12.3% over the analysis period 2022-2030. Sublingual Film, one of the segments analyzed in the report, is projected to record 11.7% CAGR and reach US$3.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Fast Dissolving Dental/Buccal Film segment is readjusted to a revised 12.8% CAGR for the next 8-year period.
The U.S. Market is Estimated at $1 Billion, While China is Forecast to Grow at 11.9% CAGR
The Oral Thin Films market in the U.S. is estimated at US$1 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 11.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.8% and 10.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9% CAGR.Select Competitors (Total 48 Featured) -
- Allergan plc
- Aquestive Therapeutics Inc.
- Indivior plc
- IntelGenx Corp.
- LTS Lohmann Therapie-Systeme AG
- Mylan NV
- NAL Pharma
- Novartis AG
- Pfizer, Inc.
- Solvay
- Sumitomo Dainippon Pharma Co., Ltd.
- ZIM Laboratories Limited
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and the publisher's Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Oral Thin Films - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Oral Thin Films by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 2: World 8-Year Perspective for Oral Thin Films by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
- Table 3: World Recent Past, Current & Future Analysis for Sublingual Film by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 4: World 8-Year Perspective for Sublingual Film by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 5: World Recent Past, Current & Future Analysis for Fast Dissolving Dental/Buccal Film by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 6: World 8-Year Perspective for Fast Dissolving Dental/Buccal Film by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Schizophrenia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 8: World 8-Year Perspective for Schizophrenia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 9: World Recent Past, Current & Future Analysis for Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 10: World 8-Year Perspective for Migraine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 11: World Recent Past, Current & Future Analysis for Opioid Dependence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 12: World 8-Year Perspective for Opioid Dependence by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 13: World Recent Past, Current & Future Analysis for Nausea & Vomiting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 14: World 8-Year Perspective for Nausea & Vomiting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 15: World Recent Past, Current & Future Analysis for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 16: World 8-Year Perspective for Other Disease Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 17: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 18: World 8-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 19: World Recent Past, Current & Future Analysis for Drug Store by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 20: World 8-Year Perspective for Drug Store by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 21: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 22: World 8-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 23: World Recent Past, Current & Future Analysis for E-Commerce by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 24: World 8-Year Perspective for E-Commerce by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 25: World Oral Thin Films Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
- UNITED STATES
- Oral Thin Films Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- Table 26: USA Recent Past, Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 27: USA 8-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2023 & 2030
- Table 28: USA Recent Past, Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 29: USA 8-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2023 & 2030
- Table 30: USA Recent Past, Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 31: USA 8-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2023 & 2030
- CANADA
- Table 32: Canada Recent Past, Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 33: Canada 8-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2023 & 2030
- Table 34: Canada Recent Past, Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 35: Canada 8-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2023 & 2030
- Table 36: Canada Recent Past, Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 37: Canada 8-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2023 & 2030
- JAPAN
- Oral Thin Films Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- Table 38: Japan Recent Past, Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 39: Japan 8-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2023 & 2030
- Table 40: Japan Recent Past, Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 41: Japan 8-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2023 & 2030
- Table 42: Japan Recent Past, Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 43: Japan 8-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2023 & 2030
- CHINA
- Oral Thin Films Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- Table 44: China Recent Past, Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 45: China 8-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2023 & 2030
- Table 46: China Recent Past, Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 47: China 8-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2023 & 2030
- Table 48: China Recent Past, Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 49: China 8-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2023 & 2030
- EUROPE
- Oral Thin Films Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- Table 50: Europe Recent Past, Current & Future Analysis for Oral Thin Films by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 51: Europe 8-Year Perspective for Oral Thin Films by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
- Table 52: Europe Recent Past, Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 53: Europe 8-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2023 & 2030
- Table 54: Europe Recent Past, Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 55: Europe 8-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2023 & 2030
- Table 56: Europe Recent Past, Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 57: Europe 8-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2023 & 2030
- FRANCE
- Oral Thin Films Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- Table 58: France Recent Past, Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 59: France 8-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2023 & 2030
- Table 60: France Recent Past, Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 61: France 8-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2023 & 2030
- Table 62: France Recent Past, Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 63: France 8-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2023 & 2030
- GERMANY
- Oral Thin Films Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- Table 64: Germany Recent Past, Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 65: Germany 8-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2023 & 2030
- Table 66: Germany Recent Past, Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 67: Germany 8-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2023 & 2030
- Table 68: Germany Recent Past, Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 69: Germany 8-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2023 & 2030
- ITALY
- Table 70: Italy Recent Past, Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 71: Italy 8-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2023 & 2030
- Table 72: Italy Recent Past, Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 73: Italy 8-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2023 & 2030
- Table 74: Italy Recent Past, Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 75: Italy 8-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2023 & 2030
- UNITED KINGDOM
- Oral Thin Films Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- Table 76: UK Recent Past, Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 77: UK 8-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2023 & 2030
- Table 78: UK Recent Past, Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 79: UK 8-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2023 & 2030
- Table 80: UK Recent Past, Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 81: UK 8-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2023 & 2030
- REST OF EUROPE
- Table 82: Rest of Europe Recent Past, Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 83: Rest of Europe 8-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2023 & 2030
- Table 84: Rest of Europe Recent Past, Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 85: Rest of Europe 8-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2023 & 2030
- Table 86: Rest of Europe Recent Past, Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 87: Rest of Europe 8-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2023 & 2030
- ASIA-PACIFIC
- Oral Thin Films Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- Table 88: Asia-Pacific Recent Past, Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 89: Asia-Pacific 8-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2023 & 2030
- Table 90: Asia-Pacific Recent Past, Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 91: Asia-Pacific 8-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2023 & 2030
- Table 92: Asia-Pacific Recent Past, Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 93: Asia-Pacific 8-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2023 & 2030
- REST OF WORLD
- Table 94: Rest of World Recent Past, Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 95: Rest of World 8-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2023 & 2030
- Table 96: Rest of World Recent Past, Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 97: Rest of World 8-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2023 & 2030
- Table 98: Rest of World Recent Past, Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 99: Rest of World 8-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2023 & 2030
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Allergan plc
- Aquestive Therapeutics Inc.
- Indivior plc
- IntelGenx Corp.
- LTS Lohmann Therapie-Systeme AG
- Mylan NV
- NAL Pharma
- Novartis AG
- Pfizer, Inc.
- Solvay
- Sumitomo Dainippon Pharma Co., Ltd.
- ZIM Laboratories Limited
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 197 |
| Published | April 2024 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 3.4 Billion |
| Forecasted Market Value ( USD | $ 8.5 Billion |
| Compound Annual Growth Rate | 12.1% |
| Regions Covered | Global |
